TScan Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
TScan Therapeutics, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 14.5% of the total amount of its stocks outstanding. This makes up a total of 3.48M shares of TScan Therapeutics, Inc.. Compared to the previous quarter, the number fell by -63.36% or -6.03M shares fewer. As for the holding position changes, 28.57% (4) of current hedge fund investors increased the number of shares held, 21.43% (3) of current holders sold a part of the shares held, and 7.14% (1) closed the holdings completely. 3 hedge funds are new holders of TScan Therapeutics, Inc. stock in Q1 2023, it is 21.43% of total holders.
Hedge funds holding TScan Therapeutics (Q1 2016 – Q1 2023)
| Q1 2016 | 1 |
|---|---|
| Q2 2016 | 1 |
| Q3 2016 | 1 |
| Q4 2016 | 1 |
| Q1 2017 | 1 |
| Q2 2017 | 0 |
| Q3 2021 | 26 |
| Q4 2021 | 28 |
| Q1 2022 | 24 |
| Q2 2022 | 23 |
| Q3 2022 | 25 |
| Q4 2022 | 28 |
| Q1 2023 | 14 |
Hedge funds changes in TScan Therapeutics positions (Q1 2016 – Q1 2023)
| Q1 2016 | 0 | 0 | 0 | 0 | 1 |
|---|---|---|---|---|---|
| Q2 2016 | 0 | 0 | 0 | 0 | 1 |
| Q3 2016 | 0 | 0 | 0 | 0 | 1 |
| Q4 2016 | 0 | 0 | 0 | 0 | 1 |
| Q1 2017 | 0 | 0 | 0 | 0 | 1 |
| Q2 2017 | 0 | 0 | 0 | 1 | -1 |
| Q3 2021 | 26 | 0 | 0 | 0 | 0 |
| Q4 2021 | 10 | 2 | 6 | 7 | 3 |
| Q1 2022 | 4 | 8 | 3 | 8 | 1 |
| Q2 2022 | 6 | 6 | 3 | 6 | 2 |
| Q3 2022 | 3 | 5 | 6 | 1 | 10 |
| Q4 2022 | 6 | 6 | 4 | 4 | 8 |
| Q1 2023 | 3 | 4 | 3 | 1 | 3 |